Browse our products by keywords

  • Proteomics
  • PerkinElmer
  • BioLegend
  • Next Generation Sequencing
  • Clinical
  • Genomics
  • Raybiotech
  • Nugen
  • Tecan Genomics
  • HTRF

Promotion

Click here to view our latest promotion.

Genomax Technologies Singapore

  • Products and Services
    • Featured Products

      • Agilent Sureselect Target Enrichment Platform

        Targeted sequencing provides a time and cost-effective...

      • Antibodies

      • Assays for High-Throughput Screening

    • Services

      Agilent Certified Service Provider

      Visit our website to find out more

  • What's New
    • News & Events
    • Promotions
  • Support
    • FAQ
    • Data Protection Notice
  • About Us
  • Suppliers
  • Contact Us
Genomax Technologies Singapore
  • Products and Services
  • What's New
    • News & Events
    • Promotions
  • Support
    • FAQ
    • Data Protection Notice
  • About Us
  • Suppliers
  • Contact Us
  • You are here:  
  • Home
  • What's New
  • News & Events

News

WEBINAR: Titration of 164 antibodies using CITE-seq on human PBMCs

Read more ...

WEBINAR: Novel Bispecific CAR-T Cells Against Hematological Cancers

Read more ...

WEBINAR: COVID-19 in Asia: Viral Transmission, Host Immunity, and Vaccination

Read more ...

WEBINAR: Improving Therapeutic Discovery by Leveraging HT-SPR to Compliment AlphaLISA

Read more ...

WEBINAR: Enabling novel technologies to effectively develop T and NK cell-based therapeutic products

Read more ...

  1. WEBINAR: Review of Guidelines for Interpreting Somatic Hypermutation Status in Chronic Lymphocytic Leukemia in the Era of High-Throughput Sequencing
  2. WEBINAR: No-wash ELISA: Fast & Sensitive Alpha & HTRF immunoassays for Research & Drug Discovery
  3. WEBINAR: Noninvasive imaging approach to quantifying NASH and assessing emerging therapeutics
  4. PRESS RELEASE: Elucigene Diagnostics Partner With Genomax Technologies

Page 1 of 2

  • Start
  • Prev
  • 1
  • 2
  • Next
  • End

Genomax Technologies Pte Ltd. All Rights Reserved.